Sarepta Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of SRPT for the last quarter is 362.93 M USD, and it's 12.22% lower compared to the previous quarter. The net income of Q2 24 is 6.46 M USD.